person · Reporting owner
GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organogenesis Holdings Inc.ORGO · Entity 6275 | 10% owner | January 09, 2025 | January 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organogenesis Holdings Inc.
Report date January 09, 2025 · Filed January 13, 2025
Jointly reported with Ades Alan A., Ades Josette, Erani Dennis, Wisdom Starr, RED Holdings, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 51,085,402 |
Reported balance
After 2025-01-09 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-01-09 · Gift · Disposed 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. |
| Class A Common StockSEC Table I · non-derivative | Direct | 51,085,402 |
Reported balance
After 2025-01-09 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy spouse | 51,085,402 |
Reported balance
After 2025-01-09 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities.
F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 09, 2025 Filed Jan 13, 2025 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 6,401,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 6,401,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| January 09, 2025 Filed Jan 13, 2025 17:03 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 6,401,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 19:22 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 1,710,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 19:22 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 1,710,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 19:22 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 1,710,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:49 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerClass A Common Stock | 500,000 | $4.06 | $2,028,500.00 |
DisclosureSEC source: 0001062993-24-019881 · form4.xml · nonDerivative · entry 1 GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 26, 2024. F2 · balance_after: Reflects the total number of securities held by the Group. Only the GN 2016 Family Trust u/a/d August 12, 2016 has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Glenn H. Nussdorf, who disclaims ownership of the shares held by the GN 2016 Family Trust u/a/d August 12, 2016, except to the extent of his pecuniary interest therein. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 19:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerClass A Common Stock | 2,550,822 | $3.16 | $8,059,832.27 |
DisclosureSEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 5 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,585,403 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F6 · balance_after: Reflects the total number of securities held by the Group. Only Glenn H. Nussdorf has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the fifth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 19:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerClass A Common Stock | 3,761,909 | $3.16 | $11,886,503.87 |
DisclosureSEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 4 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,136,225 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F5 · balance_after: Reflects the total number of securities held by the Group. Only the Alan Ades 2014 GRAT has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the fourth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Alan A. Ades, who is the Trustee of the Alan Ades 2014 GRAT, and who disclaims ownership of the shares held by the Alan Ades 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 19:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | Disposition to issuerClass A Common Stock | 294,000 | $3.16 | $928,951.80 |
DisclosureSEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,898,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F4 · balance_after: Reflects the total number of securities held by the Group. Only Alan A. Ades has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the third line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 19:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 590,332 | $3.16 | $1,865,272.02 |
DisclosureSEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,192,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F3 · balance_after: Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 19:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 224,668 | $3.16 | $709,883.48 |
DisclosureSEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,782,466 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 16:44 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 17,972 | $4.28 | $76,875.23 |
DisclosureSEC source: 0001062993-24-000799 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,007,134 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.20 to $4.34, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares being sold pursuant to the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to the second line of Table I of this Form 4, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 16:44 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 197,921 | $4.37 | $863,984.54 |
DisclosureSEC source: 0001062993-24-000799 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,025,106 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.45, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to the first line of Table I of this Form 4. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 18:28 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 25,000 | $2.07 | $51,772.50 |
DisclosureSEC source: 0001062993-23-009196 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,223,027 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.0701 to $2.0801, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| June 13, 2022 Filed Jun 13, 2022 17:44 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 29,669 | $4.89 | $145,081.41 |
DisclosureSEC source: 0001062993-22-014816 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,248,027 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $4.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:44 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 331 | $5.30 | $1,754.30 |
DisclosureSEC source: 0001062993-22-014816 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,277,696 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.31, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| June 08, 2022 Filed Jun 8, 2022 19:13 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 20,000 | $5.39 | $107,800.00 |
DisclosureSEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,278,027 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 19:13 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 50,000 | $5.49 | $274,500.00 |
DisclosureSEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,298,027 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 19:13 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 100,000 | $5.41 | $541,000.00 |
DisclosureSEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,348,027 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 4 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 7,392,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 3 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 2 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:31 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 1 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Albert Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:00 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013189 · form4.xml · nonDerivative · entry 2 Erani Dennis · CIK 0001760685 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| December 15, 2021 Filed Dec 18, 2021 02:00 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013189 · form4.xml · nonDerivative · entry 1 Erani Dennis · CIK 0001760685 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dennis Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: The reported securities, which were indirectly held by Dennis Erani, a member of the Group (as defined below), were transferred by the Dennis Erani 2014 GRAT to the Dennis Erani 2012 Issue Trust dated 12/20/12, which is a member of the Group, for no consideration. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document |
| November 18, 2021 Filed Nov 23, 2021 01:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 25,000 | $9.93 | $248,250.00 |
DisclosureSEC source: 0001062993-21-011407 · form4.xml · nonDerivative · entry 1 GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 21:27 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 150,000 | $15.31 | $2,296,500.00 |
DisclosureSEC source: 0001661181-21-000056 · edgar.xml · nonDerivative · entry 1 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,432,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.63, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 08, 2021 Filed Jun 8, 2021 19:52 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 100,000 | $15.41 | $1,541,000.00 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 3 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,582,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $16.05, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 19:52 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 94,612 | $16.14 | $1,527,037.68 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 2 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,682,133 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 19:52 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 60,000 | $16.22 | $973,200.00 |
DisclosureSEC source: 0001661181-21-000053 · edgar.xml · nonDerivative · entry 1 Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,776,745 F1 · shares: The reported securities sold were held directly by Albert Erani, who is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Albert Erani. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.30, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| May 27, 2021 Filed May 28, 2021 21:32 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 3,887,500 | $16.40 | $63,755,000.00 |
DisclosureSEC source: 0001661181-21-000049 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,836,745 F1 · shares: The reported securities sold were held directly by the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). None of the members of the Group has a pecuniary interest in the securities sold other than Alan A. Ades and the Alan Ades 2014 GRAT. F2 · price: The sale was executed in a single block trade at $16.40 per share. F3 · balance_after: Reflects the total number of securities held by the Group. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 5,417,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 6 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,724,507 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F7 · shares: The reported securities were distributed by Organo PFG LLC to Dennis Erani as Trustee of the Dennis Erani 2014 GRAT. Dennis Erani is a member of the Group (as defined below). Dennis Erani disclaims beneficial ownership of the Shares held by the Dennis Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 4,661,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 5 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,306,607 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F6 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani as Trustee of the Albert Erani 2014 GRAT. Albert Erani is a member of the Group (as defined below). Albert Erani disclaims beneficial ownership of the Shares held by the Albert Erani 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 115,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 4 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,645,478 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F5 · shares: The reported securities were distributed by Organo PFG LLC to Albert Erani, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 9,235,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,529,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F4 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades as Trustee of the Alan Ades 2014 GRAT, which is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 120,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,294,298 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F3 · shares: The reported securities were distributed by Organo PFG LLC to Alan A. Ades, who is a member of the Group (as defined below). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 23,855,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000039 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,173,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F2 · shares: The reported securities were distributed by Organo PFG LLC, which is a member of the Group (as defined below). Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 20:12 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 200,000 | $3.25 | $650,000.00 |
DisclosureSEC source: 0001661181-21-000010 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,594,976 F1 · shares: The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares. Read SEC document |
| December 29, 2020 Filed Feb 12, 2021 18:29 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 251,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000006 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,794,976 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document |
| December 29, 2020 Filed Feb 12, 2021 18:29 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 251,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000006 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,543,546 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 16:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 347,153 | $3.25 | $1,128,247.25 |
DisclosureSEC source: 0001661181-20-000036 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Robert Harry Erani Frick Trust Disclosed balance after: 68,794,976 F2 · shares: The reported securities were purchased by the Robert Harry Erani Frick Trust (the "Trust") and are held indirectly by Dennis Erani, who is a member of the Group. Susan Erani, Dennis Erani's spouse, and Glenn Nussdorf are co-trustees of the Trust. Dennis Erani disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 16:53 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 486,000 | $3.25 | $1,579,500.00 |
DisclosureSEC source: 0001661181-20-000036 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,447,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 18:30 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 10,000 | $5.03 | $50,274.00 |
DisclosureSEC source: 0001661181-19-000015 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,961,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $5.15, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 5, 2019 20:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 5,000 | $4.53 | $22,664.00 |
DisclosureSEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 4 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,951,823 F5 · shares: The reported securities were purchased and are held directly by Albert Erani, who is a member of the Group. F6 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.52 to $4.55, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 50,000 | $4.62 | $231,190.00 |
DisclosureSEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,946,823 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F4 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.92, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 100 | $4.25 | $425.00 |
DisclosureSEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,823 F3 · shares: The reported securities were purchased and are held directly by Dennis Erani, who is a member of the Group. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 50,000 | $4.38 | $218,930.00 |
DisclosureSEC source: 0001661181-19-000005 · edgar.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,723 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.48, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantCommon Stock | 182,841 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001661181-18-000047 · edgar.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,846,723 F5 · price: Received by Glenn H. Nussdorf in connection with the Merger in exchange for 90,069 shares of common stock of Organogenesis previously held by Mr. Nussdorf. F6 · ownership.direct: The reported securities are held directly by Glenn H. Nussdorf, who is a member of the Group. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:09 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantCommon Stock | 781,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001661181-18-000047 · edgar.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner ERANI ALBERT · CIK 0001074084 · Director · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,663,882 F3 · price: Received by Albert Erani in connection with the Merger in exchange for 385,174 shares of common stock of Organogenesis previously held by Mr. Erani. F4 · ownership.direct: The reported securities are held directly by Albert Erani, who is a member of the Group. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.